Report Finds Warning Letters Down, But FDA Says Enforcement Is Still Strong
This article was originally published in The Gray Sheet
Executive Summary
A report by a leading House Democrat shows that the number of warning letters issued by FDA dropped more than 50% over the last five years, but FDA says the figures don't necessarily mean the agency has grown lax in its enforcement
You may also be interested in...
Democratic Congress May Mean Greater Postmarket Focus, FDA Funding
The rise of Reps. John Dingell (D-Mich.) and Henry Waxman (D-Calif.) to top committee positions as a result of the Democrats' takeover of the House in the Nov. 7 elections could mean more attention on device safety issues in the new Congress
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?